US 10,487,097 B2Granted

4,6-di-(O-thiophosphate)-inositol-1,2,3,5-tetra-O-sulfate for C. difficile infection

AssigneeETH Zurich

InventorsMattias Ivarsson, Jean-Christophe Leroux, Bastien Castagner

Life of this patent

Estimating the term…

Abstract

The present invention relates to inositol bisthiophosphates-tetrakissulfates, particularly for use in treating symptoms associated with Clostridium difficile infection.

Claims6

Dependent claims

A compound characterized by the general formula (I)

wherein two out of six X are OPSO22− and the remaining X are OSO3−.

Dependencies are inferred from the claim text.

Facts

Application: 16/060,972Filed 12 Dec 2016
Priority: EP 1519968111 Dec 2015
Published: US 2018/0362554 A120 Dec 2018
Granted: 26 Nov 2019
Term ends: Not estimatedThe source records don’t support an estimate.

Classification4 codes

C07F 9/177
Esters of thiophosphoric acids: with cycloaliphatic alcohols
A61P 31/04
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics: antibacterial agents
C07F
Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen
A61P
Therapeutic uses of medicines

Family

US 2018/0362554 A1Pre-grant publication · published 20 Dec 2018
US 10,487,097 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…